PUBLISHER: The Business Research Company | PRODUCT CODE: 1942515
PUBLISHER: The Business Research Company | PRODUCT CODE: 1942515
Cardiac assist devices and equipment are electromechanical devices designed to aid in pumping blood from the heart to the rest of the body. These devices are used to either partially or fully replace the function of a failing heart. They help enhance blood circulation, alleviate the heart's workload, and can even provide life-saving support in critical situations.
Key types of cardiac assist devices include ventricular assist devices, intra-aortic balloon pumps, and the total artificial heart. Ventricular assist devices are specifically designed electromechanical tools for heart circulation support. These devices come in varied forms, such as transcutaneous and implantable, and find application in hospital pharmacies, ambulatory surgical centers, and emergency services.
Tariffs are impacting the cardiac assist devices and equipment market by increasing costs of imported electromechanical components, precision sensors, biocompatible materials, control systems, and power units. Hospitals and cardiac care centers in North America and Europe are most affected due to reliance on imported high-end medical devices, while Asia-Pacific faces increased costs for advanced device procurement. These tariffs are elevating treatment costs and slowing device adoption in some regions. However, they are also driving local manufacturing initiatives, regional supplier development, and innovation in cost-optimized cardiac assist technologies.
The cardiac assist devices and equipment market research report is one of a series of new reports from The Business Research Company that provides cardiac assist devices and equipment market statistics, including cardiac assist devices and equipment industry global market size, regional shares, competitors with a cardiac assist devices and equipment market share, detailed cardiac assist devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the cardiac assist devices and equipment industry. This cardiac assist devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The cardiac assist devices and equipment market size has grown strongly in recent years. It will grow from $2.35 billion in 2025 to $2.53 billion in 2026 at a compound annual growth rate (CAGR) of 7.9%. The growth in the historic period can be attributed to rising prevalence of advanced heart failure, expansion of cardiac surgery programs, increasing use of mechanical circulatory support, improvements in implantable device design, growing availability of specialized cardiac care centers.
The cardiac assist devices and equipment market size is expected to see rapid growth in the next few years. It will grow to $3.76 billion in 2030 at a compound annual growth rate (CAGR) of 10.4%. The growth in the forecast period can be attributed to increasing demand for destination therapy devices, rising adoption of remote monitoring-enabled assist systems, expansion of bridge-to-transplant applications, growing investments in next-generation cardiac devices, advancements in biocompatible materials and device miniaturization. Major trends in the forecast period include increasing adoption of implantable assist devices, rising use of minimally invasive cardiac support systems, growing integration of remote patient monitoring, expansion of pediatric and specialized cardiac devices, enhanced focus on long-term device reliability.
A rise in the prevalence of cardiovascular diseases (CVD) is boosting the demand for cardiac assist devices and equipment in both developed and developing countries. The growing need for diagnosis, monitoring, early-stage treatment, and prevention of these life-threatening conditions is driving demand for cardiac assist devices. For example, according to the American Heart Association, by 2035, approximately 45.1% of the U.S. population is expected to have some form of CVD. The total costs associated with CVD are projected to reach $1.1 trillion in 2035, with direct medical expenses estimated at $748.7 billion and indirect costs around $368 billion. Therefore, the increasing prevalence of cardiovascular diseases is fueling the growth of the cardiac assist devices and equipment market.
Major companies operating in the cardiac assist devices and equipment market are focusing on developing miniaturized interventional ventricular assist devices (VADs), such as foldable percutaneous VAD systems, to provide less-invasive circulatory support during high-risk percutaneous coronary interventions and acute cardiogenic shock. A foldable percutaneous VAD system is a catheter-delivered mechanical circulatory-support device designed for insertion through a small arterial sheath (reducing vascular access size), offering rapid left-ventricular unloading at clinically meaningful flow rates and minimizing procedural trauma compared with larger surgical pumps. For instance, in September 2023, magAssist, a China-based developer of circulatory-support devices, introduced the NyokAssist interventional ventricular assist device, which received U.S. FDA Breakthrough Device designation and completed first-in-human use. This small-bore (≈9 Fr) foldable catheter pump features an external motor to reduce hemolysis risk, is designed for straightforward delivery across the aortic arch, and achieved >3 L/min average flow during reported first-in-human high-risk PCI support.
In June 2023, Translumina, a Germany-based interventional cardiovascular device manufacturer, acquired Blue Medical Devices for an undisclosed amount. Through this acquisition, Translumina gained access to Blue Medical's drug application technology, which ensures zero drug loss during device delivery and provides a high drug concentration precisely at the target site. The acquisition also allows Translumina to incorporate this patented technology across its broader portfolio, including peripheral and neurovascular intervention products. Blue Medical Devices is a Netherlands-based company specializing in cardiac assist devices and equipment.
Major companies operating in the cardiac assist devices and equipment market are Abbott Laboratories, Berlin Heart GmbH, Abiomed Inc., Bivacor Pvt. Ltd., Calon Cardio-Technology Ltd., Cardiobridge GmbH, Cardiac Assist Inc., Braile Biomedica Ltd., Circulite Inc., Evaheart Inc., FineHeart Sarl, Getinge AB, Jarvik Heart Inc., Medtronic plc, OregonHeart, MitiHeart Corporation, Procyrion Inc., Scandinavian Real Heart AB, Syncardia Systems LLC, HeartWare International Inc., Cardiac Power Innovations, Cardionomic Inc., Carmat SA, CorWave SA, Leviticus Cardio Ltd., LivaNova PLC, MicroMed Cardiovascular Inc., Novacor SA, Thoratec Corporation, Ventracor Limited
North America was the largest region in global cardiac assist devices and equipment market in 2025. Western Europe was the second-largest region in cardiac assist devices and equipment market. The regions covered in the cardiac assist devices and equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the cardiac assist devices and equipment market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
The cardiac assist devices and equipment market consist of sales of ventricular assist devices (LVAD), intra-aortic balloon pumps, and others. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Cardiac Assist Devices And Equipment Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses cardiac assist devices and equipment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for cardiac assist devices and equipment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cardiac assist devices and equipment market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.